Investor Relations

IR Home

Recent Newsmore >
11/03/16
ConforMIS Reports Third Quarter 2016 Financial Results
BEDFORD, Mass., Nov. 03, 2016 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy, announced today financial results for the third quarter ended September 30, 2016. Q3 Summary: Total revenue of $18.6 million, up 34% year-over-year on a reported basis and up 35%  year-over-yea... 
10/24/16
ConforMIS Names Industry Veteran Mark Augusti President and Chief Executive Officer
BEDFORD, Mass., Oct. 24, 2016 (GLOBE NEWSWIRE) -- ConforMIS Inc. (NASDAQ:CFMS), a medical technology company that develops, manufactures and sells joint replacement implants that are customized to fit each patient's unique anatomy, announced today that Mark A. Augusti has been named the Company’s President and Chief Executive Officer, effective when he joins the Company on November 14, 2016.  The Company also expects that Mr. Augusti will be appointed to the Company’s Board of Directors follow... 
Upcoming Eventsmore >
01/09/17 through 01/11/17
ConforMIS, Inc. at the J.P. Morgan Conference
remind me days before the event

Enter your e-mail address 
IR Contact
Oksana Bradley
Investor Relations
Phone: (781) 374-5598
E-mail: ir@conformis.com

Media Contacts
Bill Berry
Berry & Company Public Relations
Phone: (212) 253-8881
E-mail: Bberry@berrypr.com

Lynn Granito
Berry & Company Public Relations
Phone: (212) 253-8881
E-mail: Lgranito@berrypr.com
Featured Reports
There are currently no items available.
Data provided by Nasdaq. Minimum 15 minutes delayed.